Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-01
DOI
10.3389/fonc.2022.929996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer activity of Neosetophomone B by targeting AKT/SKP2/MTH1 axis in leukemic cells
- (2022) Shilpa Kuttikrishnan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cells
- (2021) Shilpa Kuttikrishnan et al. LEUKEMIA & LYMPHOMA
- Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway
- (2020) Abdul Q. Khan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent progress in TGF-β inhibitors for cancer therapy
- (2020) Cheng-Yi Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Meroterpenoids from Neosetophoma sp.: A Dioxa[4.3.3]propellane Ring System, Potent Cytotoxicity, and Prolific Expression
- (2019) Tamam El-Elimat et al. ORGANIC LETTERS
- Shikonin derivatives for cancer prevention and therapy
- (2019) Joelle C. Boulos et al. CANCER LETTERS
- High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma
- (2019) Junjie Piao et al. GENE
- Alkaloids for cancer prevention and therapy: Current progress and future perspectives
- (2019) Arijit Mondal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
- (2019) Katie L. Owen et al. Cancers
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma
- (2017) Qing Ma et al. ONCOLOGY REPORTS
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Acute Myeloid Leukemia, Version 2.2013
- (2017) Margaret R. O’Donnell et al. Journal of the National Comprehensive Cancer Network
- Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
- (2016) Wei-de Zhong et al. OncoTargets and Therapy
- Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
- (2015) Maqbool Ahmed et al. Molecular Cancer
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma
- (2012) X. Wan et al. CANCER RESEARCH
- The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosisviamitochondrial-lysosomal cross-talk
- (2012) Christian Seitz et al. INTERNATIONAL JOURNAL OF CANCER
- The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
- (2012) L J Monteiro et al. ONCOGENE
- Negative Feedback and Adaptive Resistance to the Targeted Therapy of Cancer
- (2012) Sarat Chandarlapaty Cancer Discovery
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation
- (2011) Robin M. Ricke et al. JOURNAL OF CELL BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma
- (2010) David M. Lucas et al. CURRENT DRUG TARGETS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now